Module

Practical Approaches to Evaluating and Monitoring Cardiovascular Risk in HIV-Infected Patients

Source: Dyslipidemia and Other Cardiovascular Risk Factors in HIV: Causes, Clinical Significance, and Management Strategies

Practical Approaches to Evaluating and Monitoring Cardiovascular Risk in HIV-Infected Patients


Faculty:

  • James H. Stein, MD

CME CREDIT INFORMATION

Release Date: 12/01/06

Expiration Date: 11/30/07


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1.0 contact hour (0.1 CEUs)

Registered Nurses: 1.2 Nursing CE credits

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe strategies for evaluating cardiovascular risk in HIV-infected patients
  • Review the application of patient risk based on age, total cholesterol level, high density lipoprotein cholesterol level, smoking, and systolic blood pressure derived from the general population to the HIV-infected population
  • Discuss emerging cardiovascular risk parameters and how they may play a role in assessment of cardiovascular risk in HIV-infected patients

Topics covered include:

  • Introduction
  • HIV, HAART, and Cardiovascular Risk
  • Guidelines for Evaluating Cardiovascular Risk in Patients Receiving HAART
  • Timing of Lipid Measurements in HIV-Infected Patients
  • Role of Emerging Cardiovascular Risk Factors
  • Imaging Tests for Measuring Atherosclerotic Burden
  • Longitudinal Monitoring of Emerging Factors for Cardiovascular Risk
  • Conclusion
  • Summary and Implications for Clinical Practice
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Medical Education Collaborative and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.